MedTrace Logo

Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes With Clostridium Difficile.

NCT00377078 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2006-09-15

No results posted yet for this study

Summary

Primary objective of this pilot study is to evaluate the effect of recombinant human lactoferrin on the rate of infection with Clostridium difficile in long-term care patients supported by enteral feeding requiring broad spectrum antibiotics.

Conditions

  • Clostridium Difficile

Interventions

DRUG

recombinant human lactoferrin

Sponsors & Collaborators

Principal Investigators

  • William B Greenough, III, MD · Johns Hopkins University

  • Delia Bethell, Ph.D. · Ventria Bioscience

  • Delia Bethell, Ph.D. · Ventria Bioscience

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Completion
2007-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00377078 on ClinicalTrials.gov